Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis

Safety of prolonged use of metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility disorders in patients with systemic sclerosis

Background: Metoclopramide and domperidone are prokinetic agents commonly used to treat gastrointestinal dysmotility disorders. This study aimed to evaluate the safety and associated side effects of prolonged-use metoclopramide and domperidone as treatment for chronic gastrointestinal dysmotility di...

Full description

Bibliographic Details
Main Authors:	Saad Alkhowaiter, Maha M. Al Rasheed, Nuha Alammar, Ammar Alotaibi, Mansour Altuwaijri, Suliman Alshankiti, Mohammed A. Omair, Majid Alsahafi
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Series:	Saudi Pharmaceutical Journal
Subjects:	Gastrointestinal dysmotility systemic sclerosis (SSc) Scleroderma Interstitial lung disease (ILD) Metoclopramide Domperidone
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016424000896

Similar Items

Is the combination of domperidone and metoclopramide increasing the risk of developing serotonin syndrome?: a case report
by: Abdullah Nasser Aldosari, et al.
Published: (2024-04-01)

The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosis
by: Isabella M. Atzeni, et al.
Published: (2023-06-01)

Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance
by: Yisong Cheng, et al.
Published: (2021-08-01)

Formulation and Evaluation of Domperidone Nanoemulsions for Oral Rout
by: Mohanad N. Taher, et al.
Published: (2017-01-01)

Recent Advances in the Management of Severe Gastrointestinal Dysmotility
by: Vasant DH, et al.
Published: (2021-05-01)

The diagnostic trajectories of Danish patients with autoimmune rheumatologic disease associated interstitial lung disease: an interview-based study
by: MB Johansen, et al.
Published: (2023-01-01)

The Role of Autophagy and Apoptosis in Affected Skin and Lungs in Patients with Systemic Sclerosis
by: Vesna Spasovski, et al.
Published: (2023-07-01)

Spontaneous pneumothorax during nintedanib therapy in patients with systemic sclerosis‐associated interstitial lung disease
by: Toshiyuki Sumi, et al.
Published: (2021-03-01)

Short review on domperidone tablet
by: Shaveta Sharma, et al.
Published: (2017-01-01)

Domperidone and maternal milk volume in mothers of premature newborns
by: Tengku Ellya Fazilla, et al.
Published: (2017-02-01)

Benefits of domperidone in ambulatory acute diarrhea with severe vomiting
by: Irene A. O., et al.
Published: (2007-10-01)

The reevaluation of the role of duodenal dysmotility in the etiopathogenesis of vesicular cholelithiasis
by: Viorel Moraru, et al.
Published: (2018-10-01)

In vitro Transdermal Transport of Domperidone by Compartmental Modeling Approach
by: Sekar Ayu Pawestri, et al.
Published: (2021-01-01)

FORMULATION AND EVALUATION OF MUCOADHESIVE BUCCAL TABLET OF DOMPERIDONE MALEATE
by: Yuwaraj Dilipsingh Dixit, et al.
Published: (2013-01-01)

Use of domperidone in canine visceral leishmaniasis: gaps in veterinary knowledge and epidemiological implications
by: Bruno L Travi, et al.
Published: (2018-10-01)

Oral erythromycin for treatment of gastrointestinal dysmotility in premature infants
by: Armelia Moesri, et al.
Published: (2007-10-01)

Nintedanib in systemic sclerosis treatment: a case report
by: Maysoun Kudsi, et al.
Published: (2024-02-01)

High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?
by: Barbara Ruaro, et al.
Published: (2021-12-01)

High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients
by: Barbara Ruaro, et al.
Published: (2021-10-01)

Exploring the common pathophysiological links between IPF, SSc-ILD and post-COVID fibrosis
by: Rajesh Swarnakar, et al.
Published: (2022-01-01)

Domperidone: Pharmacists Stimulating Clinical Change for Lactation Consultants
by: Katherine Chinnery, et al.
Published: (2024-01-01)

Formulation development and evaluation of mouth dissolving film of domperidone
by: Pratikkumar Joshi, et al.
Published: (2012-01-01)

Egyptian evidence-based consensus on clinical practice recommendations for the management of systemic sclerosis
by: Yasser El Miedany, et al.
Published: (2024-02-01)

Bowel scintigraphy identifies segmental dysmotility prior to stoma closure
by: John Gerard Cassey, et al.
Published: (2021-01-01)

Esophageal motility disorders in systemic sclerosis
by: Sara Ghani, et al.
Published: (2020-03-01)

Domperidone‐induced pityriasis rosea‐like drug eruption
by: Sarra Saad, et al.
Published: (2022-04-01)

UTILIZATION OF BROMINATION REACTION FOR THE SPECTROPHOTOMETRIC ASSAY OF DOMPERIDONE IN PHARMACEUTICALS
by: O. ZENITA DEVI, et al.
Published: (2011-03-01)

Evaluation of the Additive Effect of Domperidone on Patients with Refractory Gastroesophageal Reflux Disease Symptoms; A Randomized Double Blind Clinical Trial
by: Tarang Taghvaei, et al.
Published: (2019-01-01)

Comparison of metoclopramide–dexamethasone combination and metoclopramide alone for prophylaxis of postoperative nausea vomiting in laparoscopic cholecystectomy
by: Humaira Ahmad, et al.
Published: (2023-02-01)

Effects of Domperidone on QT Interval in Children with Gastroesophageal Reflux Disease
by: Thitima Ngoenmak, et al.
Published: (2016-02-01)

Association between enteric dysmotility and GnRH antibodies: A meta-analysis
by: Karam R. Motawea, et al.
Published: (2023-10-01)

Clinical Risk Factors for Dysphagia and Esophageal Dysmotility in Systemic Sclerosis
by: Mariko Hara, et al.
Published: (2023-05-01)

Downregulation of ICCs and PDGFRα+ cells on colonic dysmotility in hirschsprung disease
by: Aiming Gu, et al.
Published: (2023-01-01)

Study of Metoclopramide Versus Metoclopramide Plus Dexamethasone for Reduction of Nausea & Vomiting after Maxillomandibular Fixation Surgery
by: Farhad Heshmati, et al.
Published: (2002-03-01)

Efficacy and Safety of Domperidone in Combination with Proton Pump Inhibitors in Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
by: Nur Fathurah Zamani, et al.
Published: (2022-09-01)

A comparative study on the effects of ondansetron and metoclopramide on postoperative nausea and vomiting in patients undergoing appendectomy and cholecystectomy
by: Mehdi Ebrahimi, et al.
Published: (2018-01-01)

Analgesic Effects of Metoclopramide Following Conventional Ovariohysterectomy in Bitches
by: Azin Tavakoli, et al.
Published: (2009-08-01)

Diagnostic Performance of Anti-Topoisomerase-I, Anti-Th/To Antibody and Anti-Fibrillarin Using Immunoblot Method in Systemic Sclerosis Related Interstitial Lung Disease Patients
by: Logito V, et al.
Published: (2023-04-01)

Early presenting hypertrophic pyloric stenosis with transient antroduodenal dysmotility in a preterm neonate: A case report
by: Sang-won Cho, et al.
Published: (2015-09-01)

A Successful Induction of Lactation in Surrogate Pregnancy with Metoclopramide and Review of Lactation Induction
by: Marzieh Shiva, et al.
Published: (2010-02-01)